Search Results - "Bor‐Sheng Ko"

Refine Results
  1. 1

    Antiviral prophylaxis for hepatitis B carriers improves the prognosis of diffuse large B‐cell lymphoma in Taiwan – a population‐based study by Huang, Huai‐Hsuan, Hsiao, Fei‐Yuan, Chen, Ho‐Min, Wang, Chen‐Yu, Ko, BorSheng

    Published in British journal of haematology (01-01-2021)
    “…Summary The prevention of hepatitis B virus (HBV) reactivation during rituximab treatment for diffuse large B‐cell lymphoma (DLBCL) is important in the…”
    Get full text
    Journal Article
  2. 2

    A Machine Learning Approach to the Classification of Acute Leukemias and Distinction From Nonneoplastic Cytopenias Using Flow Cytometry Data by Monaghan, Sara A, Li, Jeng-Lin, Liu, Yen-Chun, Ko, Ming-Ya, Boyiadzis, Michael, Chang, Ting-Yu, Wang, Yu-Fen, Lee, Chi-Chun, Swerdlow, Steven H, Ko, Bor-Sheng

    Published in American journal of clinical pathology (01-04-2022)
    “…Flow cytometry (FC) is critical for the diagnosis and monitoring of hematologic malignancies. Machine learning (ML) methods rapidly classify multidimensional…”
    Get full text
    Journal Article
  3. 3

    The epidemiology, treatment patterns, healthcare utilizations and costs of Acute Myeloid Leukaemia (AML) in Taiwan by Huang, Huai-Hsuan, Chen, Chieh-Min, Wang, Chen-Yu, Hsu, William Wei-Yuan, Chen, Ho-Min, Ko, Bor-Sheng, Hsiao, Fei-Yuan

    Published in PloS one (01-01-2022)
    “…An increasing incidence of Acute Myeloid Leukaemia (AML) has been reported in several Western countries. However, the epidemiology of AML in Asia is very…”
    Get full text
    Journal Article
  4. 4

    Stem cell transplant for mantle cell lymphoma in Taiwan by Wang, Yu-Hung, Hsieh, Ching-Yun, Hsiao, Liang-Tsai, Lin, Tung-Liang, Liu, Yi-Chang, Yao, Ming, Tan, Tran-Der, Ko, Bor-Sheng

    Published in Scientific reports (05-04-2022)
    “…Mantle cell lymphoma (MCL) is a B-cell lymphoma featuring an aggressive course and a progressive relapsing pattern. International guidelines recommend early…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The promotion of human mesenchymal stem cell proliferation by superparamagnetic iron oxide nanoparticles by Huang, Dong-Ming, Hsiao, Jong-Kai, Chen, Ying-Chun, Chien, Li-Ying, Yao, Ming, Chen, Yin-Kai, Ko, Bor-Sheng, Hsu, Szu-Chun, Tai, Lin-Ai, Cheng, Hui-Ying, Wang, Shih-Wei, Yang, Chung-Shi, Chen, Yao-Chang

    Published in Biomaterials (01-08-2009)
    “…Abstract Superparamagnetic iron oxide (SPIO) nanoparticles are very useful in cell imaging; meanwhile, however, biosafety concerns associated with their use,…”
    Get full text
    Journal Article
  7. 7

    Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017 by Huang, Shao-Yi, Chen, Ho-Min, Liao, Kai-Hsin, Ko, Bor-Sheng, Hsiao, Fei-Yuan

    Published in BMJ open (10-10-2020)
    “…ObjectiveCancers result in significant economic burdens on patients, health sectors and society. Reliable burden estimates will help guide resource allocation…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Allogeneic hematopoietic stem cell transplantation for B‐cell lymphoma in Taiwan by Lee, Chun‐Hui, Lin, Tzu‐Chien, Yao, Ming, Hsiao, Liang‐Tsai, Ko, BorSheng, Liu, Chia‐Jen, Chen, Tsai‐Yun

    Published in Cancer medicine (Malden, MA) (01-12-2023)
    “…Allogeneic hematopoietic stem cell transplantation (allo‐HSCT) is considered for patients with high‐risk B‐cell lymphoma and relapsed or refractory disease…”
    Get full text
    Journal Article
  10. 10

    Recommendations for the treatment and management of adult B‐Cell acute lymphoblastic leukemia in Asia‐Pacific: Outcomes from a pilot initiative by Lao, Zhentang, Lam, Kwong Yok, Cheung, Yuk Man Carol, Teng, Chieh‐Lin, Radhakrishnan, Vivek, Bhurani, Dinesh, Ko, BorSheng, Goh, Yeow Tee

    Published in Asia-Pacific journal of clinical oncology (01-06-2024)
    “…The outcomes of adult B‐cell acute lymphoblastic leukemia (ALL) remain poor. Recent advancements in the field of leukemia research show potential for improved…”
    Get full text
    Journal Article
  11. 11

    Tyrosine Kinase Inhibitors and Vascular Adverse Events in Patients with Chronic Myeloid Leukemia: A Population‐Based, Propensity Score‐Matched Cohort Study by Chen, Mei‐Tsen, Huang, Shih‐Tsung, Lin, Chih‐Wan, Ko, BorSheng, Chen, Wen‐Jone, Huang, Huai‐Hsuan, Hsiao, Fei‐Yuan

    Published in The oncologist (Dayton, Ohio) (01-11-2021)
    “…Background Tyrosine kinase inhibitors (TKIs) have shown long‐term survival benefits in patients with chronic myeloid leukemia (CML). Nevertheless, significant…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Hepatitis B surface antigen positivity is associated with progression of disease within 24 months in follicular lymphoma by Cheng, Chieh-Lung, Fang, Wei-Quan, Lin, Yu-Jen, Yuan, Chang-Tsu, Ko, Bor-Sheng, Tang, Jih-Luh, Tien, Hwei-Fang

    “…Purpose Studies have reported a positive association between hepatitis B surface antigen (HBsAg)-positive hepatitis B virus (HBV) infection and follicular…”
    Get full text
    Journal Article
  14. 14

    Isolation of Multipotent Cells from Human Term Placenta by Yen, B. Linju, Huang, Hsing‐I, Chien, Chih‐Cheng, Jui, Hsiang‐Yiang, Ko, BorSheng, Yao, Ming, Shun, Chia‐Tung, Yen, Men‐luh, Lee, Meng‐Chou, Chen, Yao‐Chang

    Published in Stem cells (Dayton, Ohio) (01-01-2005)
    “…Current sources of stem cells include embryonic stem cells (ESCs) and adult stem cells (ASCs). However, concerns exist with either source: ESCs, with their…”
    Get full text
    Journal Article
  15. 15

    A Chunking-for-Pooling Strategy for Cytometric Representation Learning for Automatic Hematologic Malignancy Classification by Li, Jeng-Lin, Lin, Yun-Chun, Wang, Yu-Fen, Monaghan, Sara A., Ko, Bor-Sheng, Lee, Chi-Chun

    “…Differentiating types of hematologic malignancies is vital to determine therapeutic strategies for the newly diagnosed patients. Flow cytometry (FC) can be…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20

    Correlative analysis of overall survival with clinical characteristics in 127 patients with mantle cell lymphoma: a multi-institutional cohort in Taiwan by Wang, Yu-Hung, Yu, Shan-Chi, Ko, Bor-Sheng, Yang, Yi-Tsung, Yao, Ming, Tang, Jih-Luh, Huang, Tai-Chung

    Published in International journal of hematology (01-09-2020)
    “…Mantle cell lymphoma (MCL) is a B-cell non-Hodgkin lymphoma often with extranodal involvement at diagnosis, and yet how this feature correlates with survival…”
    Get full text
    Journal Article